 HOUSTON, Aug. 06, 2021 GLOBE NEWSWIRE -- Bio-Path Holdings, Inc. NASDAQ: BPTH, a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on Friday, August 13, 2021 at 8:30 a.m. ET to report financial results for the second quarter ended June 30, 2021 and to provide a business overview. 